tecentriq for breast cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
tecentriq for breast cancer	1.92	0.3	7674	46	27
tecentriq	1.81	0.4	2842	59	9
for	0.23	0.3	38	31	3
breast	0.88	0.4	6155	21	6
cancer	0.96	0.1	7552	40	6

Keyword	CPC	PCC	Volume	Score
tecentriq for breast cancer	0.62	0.1	9950	87
tecentriq triple negative breast cancer	0.81	1	4044	4
tecentriq immunotherapy for breast cancer	1.39	0.7	5817	10
tecentriq triple-negative breast cancer	1.18	0.8	9415	20
tecentriq breast cancer fda	1.69	0.7	5325	52
abraxane tecentriq breast cancer	1	0.1	104	41
tc for triple negative breast cancer	1.16	1	3083	95
triple negative breast cancer markers	1.18	0.4	6254	83
triple negative breast cancer research	0.12	0.7	2953	19
triple negative breast cancer latest research	0.71	0.8	305	13
new research on triple negative breast cancer	0.95	0.5	3036	73
triple negative breast cancer database	1.51	0.9	3887	26
triple negative breast cancer tnbc	1.36	1	3670	6
using tecentriq and chemo	1.85	0.7	6063	20
tecentriq non small cell lung cancer	0.92	0.7	4854	57
tecentriq chemotherapy or immunotherapy	0.81	0.4	7346	35
tecentriq lung cancer reviews	1.18	0.7	4999	2
tecentriq for lung cancer	1.51	0.9	2308	81
tecentriq lung cancer combination therapy	0.85	0.5	1434	60
tecentriq chemo or immunotherapy	1.76	1	6609	58
tecentriq lung cancer approval	1.96	0.3	6389	88
tecentriq lung cancer clinical trials	1.55	0.3	292	85
is tecentriq a checkpoint inhibitor	0.35	0.6	3495	86
tecentriq for triple negative breast cancer	1.56	0.5	4014	29
tecentriq fda approval history	1.39	0.1	2274	67
tecentriq subcutaneous fda approval	1.94	1	2749	28
when was tecentriq fda approved	0.97	0.5	1693	94
tecentriq package insert fda	0.1	1	6267	32
tecentriq for liver cancer	1.24	1	7047	15
tecentriq for small cell lung cancer	1.46	0.7	5287	66
tecentriq lung cancer cost	0.48	1	6659	85